1. Ten to 13-Year Results of Delta Ceramic-on-Ceramic Total Hip Arthroplasty in Patients Less Than 30 Years Old.
- Author
-
Park JW, Ko YS, Lee YK, Ha YC, and Koo KH
- Subjects
- Male, Humans, Female, Adult, Hip Joint surgery, Treatment Outcome, Prosthesis Failure, Reoperation adverse effects, Ceramics, Prosthesis Design, Arthroplasty, Replacement, Hip adverse effects, Hip Prosthesis adverse effects, Osteolysis etiology, Osteolysis surgery, Osteolysis epidemiology, Periprosthetic Fractures etiology, Periprosthetic Fractures surgery
- Abstract
Background: We previously reported mid-term results of total hip arthroplasty (THA) using Delta ceramic-on-ceramic (CoC) bearings in 72 patients (86 hips) who were <30 years old. Noise was noted in 8 (9.3%) of the hips, no osteolysis or loosening was detected, and no patient required reoperation. The purpose of this study was to assess clinical and radiographic outcomes, complications, and survivorship at >10 years after THA using Delta CoC bearings in patients who were <30 years old., Methods: Cementless THA with a Delta CoC bearing was performed between March 2008 and January 2012 in 91 hips of 76 patients who were <30 years old. Eighty-five hips in 71 patients (44 men and 27 women) with a mean age of 25.9 years (range, 16 to 29 years) at surgery were followed for a mean of 10.9 years (range, 10 to 13 years)., Results: No ceramic bearings fractured. The incidence of squeaking increased to 5.9% (5 of 85), but the squeaking was not reproducible within individual patients. Periprosthetic osteolysis developed in 3 hips (3 patients): around the stem in 2 and around the metal shell in 1. The stem in 1 hip underwent revision because of a Vancouver type-B2 periprosthetic femoral fracture. One patient with systemic lupus erythematosus underwent irrigation and debridement for periprosthetic joint infection. Survivorship free of reoperation for any reason was 92.4% (95% confidence interval, 82.4% to 100%) at 13 years., Conclusions: The long-term results and survivorship of Delta CoC THA in patients <30 years old were favorable., Level of Evidence: Therapeutic Level II . See Instructions for Authors for a complete description of levels of evidence., Competing Interests: Disclosure: The Disclosure of Potential Conflicts of Interest forms are provided with the online version of the article ( http://links.lww.com/JBJS/H469 )., (Copyright © 2023 by The Journal of Bone and Joint Surgery, Incorporated.)
- Published
- 2023
- Full Text
- View/download PDF